Specification of Drug Substances and Products: Development and Validation of Analytical Methods - Christopher M. Riley - Grāmatas - Elsevier Health Sciences - 9780080983509 - 2013. gada 17. septembris
Ja vāks un nosaukums nesakrīt, pareizs ir nosaukums

Specification of Drug Substances and Products: Development and Validation of Analytical Methods 2. izdevums


Saņemt e-pastu, kad prece būs pieejama
Do you have a profile? Pierakstīties
Saņemiet paziņojumus par jauniem Christopher M. Riley izdevumiem
Pievienot savam iMusic vēlmju sarakstam

Not rated yet

Presents a critical analysis of the requirements and approaches to setting specifications for the new pharmaceutical products, with an emphasis on phase-appropriate development and validation of analytical methods. This title offers a guide to industry practices of analytical methodologies used in the specification of drug substances and products.


390 pages, Illustrated

Mediji Grāmatas     Hardcover Book   (Grāmata ar cieto muguriņu un vāku)
Izlaists 2013. gada 17. septembris
ISBN13 9780080983509
Izdevēji Elsevier Health Sciences
Lapas 390
Izmēri 192 × 243 × 21 mm   ·   970 g
Redaktors Riley, Christopher M. (President of Riley and Rabel Consulting Services, Maryville,MO,USA.)
Redaktors Rosanske, Thomas W. (Consultatnt, Lee's Summit, MO, USA)

Vairāk no tā paša izdevēja